172@29@16@59!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=2&s_cid=0&radar_off=1&is_revamped_header=1&is_responsive=1&sec=&priceinter=0&frommc=1!~!|commonstore|commonfiles|moneycontrol_header.php

Network18 Presents

partnered by

  • Galaxy Note20 | 20 Ultra
Moneycontrol

Network18 Presents

  • partnered by
  • Galaxy Note20 | 20 Ultra
you are here:

Nippon India Pharma Fund - Direct Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
  • NAV
    : ₹ 232.3491 -0.92%
    (as on 13th August, 2020)
Crisil Rank

Not Ranked

Rank not available for the fund
Risk-O-Meter
High

Fund has 95.47% investment in indian stocks of which 56.49% is in large cap stocks, 21.63% is in mid cap stocks, 11.66% in small cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    S&P BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • S&P BSE Healthcare TRI : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 13th August, 2020)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 06-Aug-20 10117.30 1.17% - 2.04% 78/101
1 Month 13-Jul-20 11333.60 13.34% - 6.15% 13/101
3 Month 13-May-20 12240.50 22.41% - 19.75% 25/101
6 Month 13-Feb-20 13399.40 33.99% - -3.98% 4/101
YTD 01-Jan-20 14373.30 43.73% - -0.17% 6/98
1 Year 13-Aug-19 15843.10 58.43% 58.23% 10.27% 5/96
2 Year 13-Aug-18 15041.40 50.41% 22.61% 0.53% 4/81
3 Year 11-Aug-17 18557.90 85.58% 22.82% 4.07% 3/74
5 Year 13-Aug-15 15320.70 53.21% 8.90% 5.94% 18/69
Since Inception 02-Jan-13 33257.00 232.57% 17.09% 10.07% 11/101

SIP Returns (NAV as on 13th August, 2020)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 13-Aug-19 12000 16669.28 38.91 % 78.67 %
2 Year 13-Aug-18 24000 34351.21 43.13 % 38.69 %
3 Year 11-Aug-17 36000 53997.98 49.99 % 28.14 %
5 Year 13-Aug-15 60000 93183.65 55.31 % 17.63 %
 

Tax Treatment

Portfolio (Updated on 31st Jul,2020)

Equity Holding : 95.47% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 95.47%
No of Stocks : 20 (Category Avg - 33.15) | Large Cap Investments : 56.49%| Mid Cap Investments : 21.63% | Small Cap Investments : 11.66% | Other : 5.69%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Dr. Reddys Laboratories Ltd. Pharmaceuticals 3549 10.15% 0.65% 11.04% (Mar 2020) 6.99% (Aug 2019) 7.85 L 40.00 k
Aurobindo Pharma Ltd. Pharmaceuticals 3410.9 9.76% -0.72% 11.96% (May 2020) 5.49% (Nov 2019) 39.00 L -3.00 L
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 3350.2 9.58% -0.06% 12.32% (Aug 2019) 9.58% (Jul 2020) 63.01 L 0.00
Cipla Ltd. Pharmaceuticals 3240.7 9.27% -0.67% 10.4% (May 2020) 7.85% (Sep 2019) 45.00 L -3.00 L
Divis Laboratories Ltd. Pharmaceuticals 3140.1 8.98% 1.24% 10.71% (Sep 2019) 7.74% (Jun 2020) 12.00 L 1.50 L
Lupin Ltd. Pharmaceuticals 3057.6 8.75% -0.68% 9.43% (Jun 2020) 4.76% (Feb 2020) 33.00 L 1.00 L
Fortis Healthcare Ltd. Hospital 1987.7 5.69% 0.01% 6.89% (Oct 2019) 4.1% (May 2020) 1.44 Cr 0.00
Thyrocare Technologies Ltd. Healthcare service providers 1796.8 5.14% 0.94% 5.94% (Feb 2020) 4.2% (Jun 2020) 25.61 L 9.42 k
Syngene International Ltd. Pharmaceuticals 1706.4 4.88% -1.47% 6.67% (Sep 2019) 4.39% (Mar 2020) 35.00 L -0.14 Cr
Sanofi India Ltd. Pharmaceuticals 1359.4 3.89% -0.57% 5.82% (Aug 2019) 3.89% (Jul 2020) 1.75 L 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
Reverse Repo Reverse Repo 5.30%
Margin Margin 0.04%
Net Receivables Net Receivables -0.81%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 31st July, 2020)

  • Standard Deviation

    High volatility
    20.81vs16.34
    Category Avg
  • Beta

    High volatility
    0.85vs0.54
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    0.8vs-0.01
    Category Avg
  • Jension's Alpha

    Better risk adjusted returns
    8.16vs-1.12
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
DSP Healthcare Fund - Direct Plan - Growth NA 570.53 17.41 29.22 33.60 69.27 0.00
Mirae Asset Healthcare Fund - Direct Plan - Growth NA 772.77 15.21 24.89 37.72 67.22 0.00
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Growth NA 1748.67 13.17 27.36 36.95 61.69 0.00
UTI Healthcare - Direct Plan - Growth NA 541.76 15.65 25.80 35.46 60.94 17.22
SBI Healthcare Opportunities Fund - Direct Plan - Growth NA 1284.30 14.89 25.02 30.07 58.20 14.61
IDBI Healthcare Fund - Direct Plan - Growth NA 41.05 13.75 20.71 32.67 57.17 0.00
Tata India Pharma & Heathcare Fund - Direct Plan - Growth NA 272.79 14.99 22.11 30.12 50.02 19.63
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan - Growth NA 305.17 14.45 21.10 25.40 46.05 0.00
Franklin India Technology Fund - Direct - Growth NA 310.49 12.71 29.34 13.30 32.21 20.67
Aditya Birla Sun Life Digital India Fund - Direct Plan - Growth NA 490.31 17.99 35.77 11.90 30.59 23.48

More Funds from Nippon India Mutual Fund

Out of 151 mutual fund schemes offered by this AMC, 4 is/are ranked 4 * , 9 is/are ranked 3 * , 4 is/are ranked 2 * , 10 is/are ranked 1 * , and 124 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Liquid Fund - Direct Plan - Growth 3 29333.59 0.28 0.97 2.45 5.29 6.65
Nippon India Floating Rate Fund - Direct Plan - Growth 3 13567.97 0.22 4.04 6.33 11.45 8.43
Nippon India Large Cap Fund - Direct Plan - Growth 1 10237.53 6.81 21.15 -12.93 -1.29 2.63
Nippon India Tax Saver Fund - Direct Plan - Growth 1 8609.72 5.01 17.34 -17.43 -4.11 -7.51
Nippon India Small Cap Fund - Direct Plan - Growth 3 8321.91 10.93 30.96 -5.04 13.07 3.29
Nippon India Short Term Fund - Direct Plan - Growth 3 8291.37 0.34 3.55 5.24 10.56 8.20
Nippon India Arbitrage Fund - Direct Plan - Growth 3 7575.58 0.25 0.81 2.46 5.42 6.63
Nippon India Multicap Fund - Direct Plan - Growth 1 7501.44 7.27 22.79 -18.46 -6.68 -0.13
Nippon India Growth Fund - Direct Plan - Growth 3 6508.65 11.55 27.77 -6.62 11.84 4.57
Nippon India Banking & PSU Debt Fund - Direct Plan - Growth 4 5424.45 0.17 3.85 6.31 11.75 9.09

Forum

+ See More